These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
762 related articles for article (PubMed ID: 28687110)
1. Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment. Magerl M; Germenis AE; Maas C; Maurer M Immunol Allergy Clin North Am; 2017 Aug; 37(3):571-584. PubMed ID: 28687110 [TBL] [Abstract][Full Text] [Related]
2. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901 [TBL] [Abstract][Full Text] [Related]
3. Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations. de Maat S; Björkqvist J; Suffritti C; Wiesenekker CP; Nagtegaal W; Koekman A; van Dooremalen S; Pasterkamp G; de Groot PG; Cicardi M; Renné T; Maas C J Allergy Clin Immunol; 2016 Nov; 138(5):1414-1423.e9. PubMed ID: 27130860 [TBL] [Abstract][Full Text] [Related]
4. Hereditary angioedema with normal C1-inhibitor: Clinical and genetic characterization of 15 Portuguese unrelated families. Dias de Castro E; Pinhal AL; Bragança M; Parente Freixo J; Martinho A Ann Allergy Asthma Immunol; 2024 Jun; 132(6):730-736. PubMed ID: 38342132 [TBL] [Abstract][Full Text] [Related]
5. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema. Deroux A; Boccon-Gibod I; Fain O; Pralong P; Ollivier Y; Pagnier A; Djenouhat K; Du-Thanh A; Gompel A; Faisant C; Launay D; Bouillet L Clin Exp Immunol; 2016 Sep; 185(3):332-7. PubMed ID: 27271546 [TBL] [Abstract][Full Text] [Related]
6. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant. Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O; Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting. Craig TJ; Bernstein JA; Farkas H; Bouillet L; Boccon-Gibod I Int Arch Allergy Immunol; 2014; 165(2):119-27. PubMed ID: 25401373 [TBL] [Abstract][Full Text] [Related]
8. A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE). Bork K Clin Rev Allergy Immunol; 2016 Oct; 51(2):183-92. PubMed ID: 27207174 [TBL] [Abstract][Full Text] [Related]
9. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway. Kaplan AP; Joseph K Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213 [TBL] [Abstract][Full Text] [Related]
10. A Retrospective Analysis of Long-Term Prophylaxis with Berotralstat in Patients with Hereditary Angioedema and Acquired C1-Inhibitor Deficiency-Real-World Data. Johnson F; Stenzl A; Hofauer B; Heppt H; Ebert EV; Wollenberg B; Lochbaum R; Hahn J; Greve J; Trainotti S Clin Rev Allergy Immunol; 2023 Dec; 65(3):354-364. PubMed ID: 37914894 [TBL] [Abstract][Full Text] [Related]
11. Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels. Joseph K; Tholanikunnel BG; Wolf B; Bork K; Kaplan AP J Allergy Clin Immunol; 2016 Jun; 137(6):1822-1829.e1. PubMed ID: 26395818 [TBL] [Abstract][Full Text] [Related]
12. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment. Zeerleder S; Levi M Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196 [TBL] [Abstract][Full Text] [Related]
13. A clinical evaluation of patients with known mutations (plasminogen and factor XII) with a focus on prophylactic treatment. Lochbaum R; Trainotti S; Hoffmann TK; Greve J; Hahn J J Dermatolog Treat; 2024 Dec; 35(1):2290362. PubMed ID: 38086754 [TBL] [Abstract][Full Text] [Related]
14. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis. Joseph K; Tholanikunnel TE; Kaplan AP Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645 [TBL] [Abstract][Full Text] [Related]
15. Recent advances in the management of hereditary angioedema. Hemperly SE; Agarwal NS; Xu YY; Zhi YX; Craig TJ J Am Osteopath Assoc; 2013 Jul; 113(7):546-55. PubMed ID: 23843378 [TBL] [Abstract][Full Text] [Related]
16. Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence. Bork K; Machnig T; Wulff K; Witzke G; Prusty S; Hardt J Orphanet J Rare Dis; 2020 Oct; 15(1):289. PubMed ID: 33059692 [TBL] [Abstract][Full Text] [Related]
17. Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations. Bork K; Wulff K; Witzke G; Hardt J Allergy; 2015 Aug; 70(8):1004-12. PubMed ID: 25952149 [TBL] [Abstract][Full Text] [Related]
18. Periodic Severe Angioedema without Exogenous Hormone Exposure. Nabavi M; Bahrami S; Arshi S; Rezaeifar A; Bemanian MH; Fallahpour M; Shokri S; Tehrani H Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):120-124. PubMed ID: 33639628 [TBL] [Abstract][Full Text] [Related]
19. Hereditary angioedema due to C1-inhibitor deficiency in Macedonia: clinical characteristics, novel SERPING1 mutations and genetic factors modifying the clinical phenotype. Grivčeva-Panovska V; Košnik M; Korošec P; Andrejević S; Karadža-Lapić L; Rijavec M Ann Med; 2018 May; 50(3):269-276. PubMed ID: 29513108 [TBL] [Abstract][Full Text] [Related]
20. Hereditary angioedema: Pathophysiology (HAE type I, HAE type II, and HAE nC1-INH). Wedner HJ Allergy Asthma Proc; 2020 Nov; 41(Suppl 1):S14-S17. PubMed ID: 33109319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]